Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Luca Pani

Showing results (1-10 of 140) with videos related to

Pageof 14
Sort By:
Clinical Drug Investigation|May 20, 2021
New Models for the Evaluation of Specialized Medicinal Products: Beyond Conventional Health Technology Assessment and PricingLuca Pani, Karin Becker
Expert Opinion on Drug Delivery|March 26, 2009
Expected clinical benefits of paliperidone extended-release formulation when compared with risperidone immediate-releaseLuca Pani, Giorgio Marchese
Journal of Clinical Neurophysiology : Official Publication of the American Electroencephalographic Society|May 7, 2021
Biomarkers and Surrogate End points in Multiple Sclerosis Trials: Regulatory IssuesMark B Skeen, Luca Pani
European Journal of Pharmacology|October 28, 2004
The atypical antipsychotic quetiapine increases both noradrenaline and dopamine release in the rat prefrontal cortexLuigi Pira, Raymond Mongeau, Luca Pani
Behavioural Pharmacology|August 31, 2010
Quetiapine anxiolytic-like effect in the Vogel conflict test is serotonin dependentCarla Pisu, Luigi Pira, Luca Pani
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|June 10, 2022
The association between onabotulinumtoxinA and anti-CGRP monoclonal antibodies: a reliable option for the optimal treatment of chronic migraineSimona Guerzoni, Carlo Baraldi, Luca Pani
European Psychiatry : the Journal of the Association of European Psychiatrists|April 10, 2007
Antipsychotic efficacy: relationship to optimal D2-receptor occupancyLuca Pani, Luigi Pira, Giorgio Marchese
Therapeutic Innovation & Regulatory Science|September 20, 2018
Insights Into the Decision Making of Advisory Groups to the Italian Medicines AgencyMichele Marangi, Silvia Miriam Cammarata, Luca Pani
Chemistry and Physics of Lipids|June 1, 2005
Effect of 1-butanol on the microstructure of lecithin/water/tripalmitin systemFrancesca Caboi, Paolo Lazzari, Luca Pani, et al.
Journal of Psychiatric Research|June 23, 2026
Calibrated clinical judgment in psychiatric drug trials: Beyond psychometric scalesLuca Pani, Gary S Sachs, Nina R Schooler
Pageof 14

Showing results (1-10 of 140) with videos related to

Sort By:
Pageof 14
Clinical Drug Investigation|May 20, 2021
New Models for the Evaluation of Specialized Medicinal Products: Beyond Conventional Health Technology Assessment and PricingLuca Pani, Karin Becker
Expert Opinion on Drug Delivery|March 26, 2009
Expected clinical benefits of paliperidone extended-release formulation when compared with risperidone immediate-releaseLuca Pani, Giorgio Marchese
Journal of Clinical Neurophysiology : Official Publication of the American Electroencephalographic Society|May 7, 2021
Biomarkers and Surrogate End points in Multiple Sclerosis Trials: Regulatory IssuesMark B Skeen, Luca Pani
European Journal of Pharmacology|October 28, 2004
The atypical antipsychotic quetiapine increases both noradrenaline and dopamine release in the rat prefrontal cortexLuigi Pira, Raymond Mongeau, Luca Pani
Behavioural Pharmacology|August 31, 2010
Quetiapine anxiolytic-like effect in the Vogel conflict test is serotonin dependentCarla Pisu, Luigi Pira, Luca Pani
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|June 10, 2022
The association between onabotulinumtoxinA and anti-CGRP monoclonal antibodies: a reliable option for the optimal treatment of chronic migraineSimona Guerzoni, Carlo Baraldi, Luca Pani
European Psychiatry : the Journal of the Association of European Psychiatrists|April 10, 2007
Antipsychotic efficacy: relationship to optimal D2-receptor occupancyLuca Pani, Luigi Pira, Giorgio Marchese
Therapeutic Innovation & Regulatory Science|September 20, 2018
Insights Into the Decision Making of Advisory Groups to the Italian Medicines AgencyMichele Marangi, Silvia Miriam Cammarata, Luca Pani
Chemistry and Physics of Lipids|June 1, 2005
Effect of 1-butanol on the microstructure of lecithin/water/tripalmitin systemFrancesca Caboi, Paolo Lazzari, Luca Pani, et al.
Journal of Psychiatric Research|June 23, 2026
Calibrated clinical judgment in psychiatric drug trials: Beyond psychometric scalesLuca Pani, Gary S Sachs, Nina R Schooler
Pageof 14